Onyx Bridge Wealth Group
PFE icon

Onyx Bridge Wealth Group’s Pfizer PFE Stock Holding History

Onyx Bridge Wealth Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.4M Buy
49,253
+1,006
+2% +$26.8K 0.12% 136
2026
Q2 		$1.16M Sell
48,247
-894
-2% -$23.4K 0.1% 141
2026
Q1 		$1.38M Buy
49,141
+1,282
+3% +$34.1K 0.15% 123
2025
Q4 		$1.19M Buy
47,859
+1,336
+3% +$33.7K 0.13% 128
2025
Q3 		$1.19M Buy
46,523
+6,614
+17% +$163K 0.13% 127
2025
Q2 		$967K Buy
39,909
+7,813
+24% +$182K 0.13% 125
2025
Q1 		$813K Sell
32,096
-1,118
-3% -$29.3K 0.12% 116
2024
Q4 		$881K Buy
33,214
+2,290
+7% +$62.1K 0.13% 109
2024
Q3 		$895K Buy
30,924
+5,802
+23% +$169K 0.13% 110
2024
Q2 		$703K Buy
25,122
+484
+2% +$13.3K 0.12% 120
2024
Q1 		$626K Buy
24,638
+5,596
+29% +$155K 0.11% 126
2023
Q4 		$548K Buy
19,042
+1,841
+11% +$55.7K 0.11% 123
2023
Q3 		$571K Buy
17,201
+1,852
+12% +$65.5K 0.13% 122
2023
Q2 		$563K Buy
15,349
+5,029
+49% +$196K 0.13% 115
2023
Q1 		$421K Buy
10,320
+54
+0.5% +$2.33K 0.17% 98
2022
Q4 		$523K Sell
10,266
-12
-0.1% -$575 0.21% 74
2022
Q3 		$432K Buy
10,278
+226
+2% +$11K 0.2% 85
2022
Q2 		$515K Sell
10,052
-3,684
-27% -$188K 0.23% 65
2022
Q1 		$683K Buy
13,736
+1,453
+12% +$75.4K 0.26% 45
2021
Q4 		$696K Buy
12,283
+323
+3% +$16K 0.23% 53
2021
Q3 		$494K Buy
11,960
+6,561
+122% +$291K 0.19% 68
2021
Q2 		$218K Sell
5,399
-2,360
-30% -$91.8K 0.09% 107
2021
Q1 		$281K Buy
+7,759
New +$275K 0.14% 74

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Onyx Bridge Wealth Group's PFE Position: Q3 2026 in Review

Onyx Bridge Wealth Group increased its Pfizer (PFE) stake by 2.1% in Q3 2026, buying an estimated $26.8K and bringing the position to 49,253 shares worth $1.4M. The position accounts for 0.12% of the portfolio, ranked #136.

Onyx Bridge Wealth Group first reported a position in PFE in Q1 2021 and has held it in 23 quarters since. 1,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Onyx Bridge Wealth Group held 49,253 shares of Pfizer worth $1.4M as of Q3 2026.
  • Onyx Bridge Wealth Group bought 1,006 Pfizer shares in Q3 2026, an estimated $26.8K.
  • Pfizer made up 0.12% of Onyx Bridge Wealth Group's portfolio in Q3 2026, its #136 holding.
  • Onyx Bridge Wealth Group first reported a position in Pfizer in Q1 2021 and has held it in 23 quarters since.
  • 1,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Onyx Bridge Wealth Group's 13F filing for Q3 2026, filed 16 Oct 2026.